Hunan Jiudian Pharmaceutical Co., Ltd. (SHE:300705)

SHE:300705 Revenue

Hunan Jiudian Pharmaceutical had revenue of 691.60M CNY in the quarter ending June 30, 2026, a decrease of -15.24%. This brings the company's total for the last twelve months to 2.89B, down -6.20% year-over-year. In the year 2025, Hunan Jiudian Pharmaceutical had annual revenue of 3.11B with 6.15% growth. That makes Hunan Jiudian Pharmaceutical the 12,084th largest company in the world by revenue and 2,065th in China.

• Revenue (ttm): 2.89B
• Revenue Growth: -6.20%
• P/S Ratio: 1.80
• Revenue / Employee: 1.26M
• Employees: 2,298
• Market Cap: 5.20B

Revenue Chart

Chart

Chart

Revenue by Geography

Chart

• East China 1.12B 35.9%
• Central China 542.78M 17.4%
• South China 392.54M 12.6%
• South-West China 375.30M 12.1%
• North China 327.58M 10.5%
• North-West China 184.45M 5.9%
• North-East China 108.27M 3.5%
• Other 63.75M 2.0%

Fiscal year ended Dec 31, 2025 See the full SHE:300705 breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	3.11B	180.22M	6.15%
Dec 31, 2024	2.93B	238.17M	8.85%
Dec 31, 2023	2.69B	366.30M	15.75%
Jan 1, 2023	2.33B	698.55M	42.92%
Jan 1, 2022	1.63B	649.51M	66.40%

Data Source: S&P Global Market Intelligence Last updated: Aug 21, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 23, 2026

Data Sources Report a data error